Avid Bioservices Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Avid Bioservices Stock Forecast and Price Target
The average price target of $13.00 for Avid Bioservices's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 70.38% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $16.00 and a low estimate of $8.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
70.38% Upside
Avid Bioservices Fair Value Forecast for 2023 - 2025 - 2030
Avid Bioservices's Price has increased by 100.00% In the last three years, going from $0.00 to $5.03. In the next year, analysts expect Fair Value to reach $6.91 – an increase of 37.50%. For the next six years, the forecast is for Fair Value to grow by 136.99%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$568.72 | Buy/Sell | $591.94 | 8.58% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF510.40 | Buy/Sell | CHF516.89 | 14.62% |
| A207940 Stock Forecast | Samsung Biologics | Buy |
7
|
₩781.00k | Buy/Sell | ₩0.00B | 34.44% |
| CRL Stock Forecast | Charles River Laboratories Int... | Outperform |
16
|
$229.00 | Buy/Sell | $229.97 | 20.85% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.85 | Buy/Sell | $49.29 | 13.70% |
Avid Bioservices Revenue Forecast for 2023 - 2025 - 2030
Avid Bioservices's Revenue has increased by 150.03% In the last three years, going from $59.70M to $149.27M. In the next year, analysts expect Revenue to reach $181.38M – an increase of 21.51%. For the next six years, the forecast is for Revenue to grow by 220.90%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2269 Stock Forecast | WuXi Biologics (Cayman) | Outperform |
8
|
HK$13.74 | Buy/Sell | HK$69.40 | 47.82% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
9.74€ | Buy/Sell | 37.33€ | 161.81% |
| EBS Stock Forecast | Emergent BioSolutions | Outperform |
16
|
$1.88 | Buy/Sell | $5.00 | 165.96% |
.jpg)
Avid Bioservices EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Avid Bioservices's EBITDA has grown from $-7.49M to $10.91M – a 245.66% increase. Next year, analysts are expecting EBITDA to reach $35.80M – an increase of 228.14%. Over the next six years, the forecast is for EBITDA to grow by 1229.06%.
Avid Bioservices EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Avid Bioservices's EBIT has grown by 134.94%, rising from $-10.59M to $3.70M. For next year, analysts predict EBIT of $7.99M, which would mean an increase of 115.95%. Over the next six years, experts predict that Avid Bioservices's EBIT will grow at a rate of 2394.86%.
Avid Bioservices EPS Price Prediction Forecast for 2023 - 2025 - 2030
Avid Bioservices's EPS has increased by 161.54% In the last three years, going from $-0.26 to $0.16. In the next year, analysts expect EPS to reach $0.22 – an increase of 37.50%. For the next six years, the forecast is for EPS to grow by 136.99%.
.jpg)